Michael Nothnagel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Michael Nothnagel has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:
Stefan Schreiber
Institute of Clinical Molecular Biology, Kiel University, Kiel, 24105, Germany
40 shared publicationsMichael Krawczak
Institute of Medical Informatics and Statistics, Christian-Albrechts University, Kiel, Germany
26 shared publicationsAndre Franke
Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, University Hospital Schleswig-Holstein, 24105 Kiel, Germany
19 shared publications- Jochen Hampe
University Hospital Carl Gustav Carus at the Technical University of Dresden 01307 Dresden Germany
18 shared publications Peter Nürnberg
Cologne Center for Genomics, University of Cologne, Cologne, Germany
18 shared publications- Philip Rosenstiel
Institute of Clinical Molecular Biology, Kiel University and University Hospital Schleswig-Holstein, Kiel, Germany
14 shared publications
Latest Publications
- Open Access
- 8 September 2026
- Published by Springer Nature in European Journal of Human Genetics
- p. 1-8
Appreciating diversity: a review of the Iranian genomic landscape
Understanding population structure is crucial for designing and interpreting human genetic studies. This is of particular importance for Iran as a large, ethnically diverse country whose population has often been treated as a genetically homogenous entity. Here, we synthesize published literature on the genetic structure of the Iranian population. We further complement this by recapitulating the geographic, historic, and ethnic background, by comparisons with neighboring countries, and by reviewing autozygosity in Iran. This synthesis confirms large genetic diversity, likely building upon an autochthonous component that was reshaped by multiple migrations. The substantial autosomal substructure falls apart into groups of largely shared genetic ancestry (Central Iranian Cluster) and those with substantial admixture in the past. Structure with respect to uniparental markers is less pronounced. We also find consistency for generally high but varying levels of autozygosity, influenced by ethnicity, residence, and socioeconomic factors. Finally, we recapitulate some examples for geographical differences in disease prevalence and (founder) mutation carrier frequency. Our synthesis emphasizes the need to account for this diversity in human genetic studies in the Iranian population. We provide conclusions for the design of such studies and state expectations on the transferability of genetic findings and genomic predictions, such as polygenic scores, within Iran as well as to neighboring countries. Iran’s diversity and geographic location provide renewed motivation for conducting population genetic and ancient DNA studies as well as providing genomic reference resources in this part of the world.
- 8 September 2026
- Published by Springer Nature in European Journal of Human Genetics
- p. 1-8
Open AccessAppreciating diversity: a review of the Iranian genomic landscape
Understanding population structure is crucial for designing and interpreting human genetic studies. This is of particular importance for Iran as a large, ethnically diverse country whose population has often been treated as a genetically homogenous entity. Here, we synthesize published literature on the genetic structure of the Iranian population. We further complement this by recapitulating the geographic, historic, and ethnic background, by comparisons with neighboring countries, and by reviewing autozygosity in Iran. This synthesis confirms large genetic diversity, likely building upon an autochthonous component that was reshaped by multiple migrations. The substantial autosomal substructure falls apart into groups of largely shared genetic ancestry (Central Iranian Cluster) and those with substantial admixture in the past. Structure with respect to uniparental markers is less pronounced. We also find consistency for generally high but varying levels of autozygosity, influenced by ethnicity, residence, and socioeconomic factors. Finally, we recapitulate some examples for geographical differences in disease prevalence and (founder) mutation carrier frequency. Our synthesis emphasizes the need to account for this diversity in human genetic studies in the Iranian population. We provide conclusions for the design of such studies and state expectations on the transferability of genetic findings and genomic predictions, such as polygenic scores, within Iran as well as to neighboring countries. Iran’s diversity and geographic location provide renewed motivation for conducting population genetic and ancient DNA studies as well as providing genomic reference resources in this part of the world.
- Open Access
Genetic risk factor identification for common epilepsies guided by integrative omics data analysis
Objective: Genetic generalized epilepsies (GGEs) comprise the most common genetically determined epilepsy syndromes, following a complex mode of inheritance. Although many important common and rare genetic factors causing or contributing to these epilepsies have been identified in the past decades, many features of the genetic architecture are still insufficiently understood. This study integrates genome‐wide association study (GWAS) data from the International League Against Epilepsy Consortium on Complex Epilepsies with transcriptome‐wide association studies to identify genes whose genetically regulated expression levels are associated with epilepsy. Methods: To achieve this, we used multiple computational approaches, including MAGMA, a tool for gene analysis of GWAS data, and its derivatives E‐MAGMA and H‐MAGMA, to improve gene mapping accuracy by utilizing tissue‐specific expression and chromatin interaction data. Furthermore, we developed ME‐MAGMA to incorporate methylation quantitative trait loci data, providing insights into epigenetic factors. Results: We identified a total of 897 false discovery rate‐corrected (<.05) candidates. These include voltage‐gated calcium channels, voltage‐gated potassium channels, and other genes such as NPRL2 , CACNB2 , and KCNT1 associated with epilepsy pathogenesis that act as key players in neuronal communication and signaling in the brain. Significance: In this study, we propose new candidate genes to expand the dataset of potential epilepsy‐causing genes. Further research on these genes may enhance our understanding of the complex regulatory mechanisms underlying GGE and other types of epilepsy, potentially revealing targets for therapeutic intervention.
Open AccessGenetic risk factor identification for common epilepsies guided by integrative omics data analysis
Objective: Genetic generalized epilepsies (GGEs) comprise the most common genetically determined epilepsy syndromes, following a complex mode of inheritance. Although many important common and rare genetic factors causing or contributing to these epilepsies have been identified in the past decades, many features of the genetic architecture are still insufficiently understood. This study integrates genome‐wide association study (GWAS) data from the International League Against Epilepsy Consortium on Complex Epilepsies with transcriptome‐wide association studies to identify genes whose genetically regulated expression levels are associated with epilepsy. Methods: To achieve this, we used multiple computational approaches, including MAGMA, a tool for gene analysis of GWAS data, and its derivatives E‐MAGMA and H‐MAGMA, to improve gene mapping accuracy by utilizing tissue‐specific expression and chromatin interaction data. Furthermore, we developed ME‐MAGMA to incorporate methylation quantitative trait loci data, providing insights into epigenetic factors. Results: We identified a total of 897 false discovery rate‐corrected (<.05) candidates. These include voltage‐gated calcium channels, voltage‐gated potassium channels, and other genes such as NPRL2 , CACNB2 , and KCNT1 associated with epilepsy pathogenesis that act as key players in neuronal communication and signaling in the brain. Significance: In this study, we propose new candidate genes to expand the dataset of potential epilepsy‐causing genes. Further research on these genes may enhance our understanding of the complex regulatory mechanisms underlying GGE and other types of epilepsy, potentially revealing targets for therapeutic intervention.
- Open Access
- 3 January 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-11
A genome-wide association meta-analysis implicates Hedgehog and Notch signaling in Dupuytren’s disease
Dupuytren’s disease (DD) is a highly heritable fibrotic disorder of the hand with incompletely understood etiology. A number of genetic loci, including Wnt signaling members, have been previously identified. Our overall aim was to identify novel genetic loci, to prioritize genes within the loci for functional studies, and to assess genetic correlation with associated disorders. We performed a meta-analysis of six DD genome-wide association studies from three European countries and extensive bioinformatic follow-up analyses. Leveraging 11,320 cases and 47,023 controls, we identified 85 genome-wide significant single nucleotide polymorphisms in 56 loci, of which 11 were novel, explaining 13.3–38.1% of disease variance. Gene prioritization implicated the Hedgehog and Notch signaling pathways. We also identified a significant genetic correlation with frozen shoulder. The pathways identified highlight the potential for new therapeutic targets and provide a basis for additional mechanistic studies for a common disorder that can severely impact hand function.
- 3 January 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-11
Open AccessA genome-wide association meta-analysis implicates Hedgehog and Notch signaling in Dupuytren’s disease
Dupuytren’s disease (DD) is a highly heritable fibrotic disorder of the hand with incompletely understood etiology. A number of genetic loci, including Wnt signaling members, have been previously identified. Our overall aim was to identify novel genetic loci, to prioritize genes within the loci for functional studies, and to assess genetic correlation with associated disorders. We performed a meta-analysis of six DD genome-wide association studies from three European countries and extensive bioinformatic follow-up analyses. Leveraging 11,320 cases and 47,023 controls, we identified 85 genome-wide significant single nucleotide polymorphisms in 56 loci, of which 11 were novel, explaining 13.3–38.1% of disease variance. Gene prioritization implicated the Hedgehog and Notch signaling pathways. We also identified a significant genetic correlation with frozen shoulder. The pathways identified highlight the potential for new therapeutic targets and provide a basis for additional mechanistic studies for a common disorder that can severely impact hand function.
- 10 October 2023
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 75, S157-S158
W100. ASSOCIATIONS OF SMOKING BEHAVIOR WITH POLYGENIC RISK SCORES FOR NICOTINE USE AND PARENTAL FAMILY HISTORY OF SMOKING
- 10 October 2023
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 75, S157-S158
W100. ASSOCIATIONS OF SMOKING BEHAVIOR WITH POLYGENIC RISK SCORES FOR NICOTINE USE AND PARENTAL FAMILY HISTORY OF SMOKING
- Open Access
- 1 January 2023
- Published by Oxford University Press (OUP) in Bioinformatics Advances
- Vol. 3 (1) , vbad176
SMapper: visualizing spatial prevalence data of all types, including sparse and incomplete datasets
Motivation: We introduce SMapper, a novel web and software tool for visualizing spatial prevalence data of all types including those suffering from incomplete geographic coverage and insufficient sample sizes. We demonstrate the benefits of our tool in overcoming interpretational issues with existing tools caused by such data limitations. We exemplify the use of SMapper by applications to human genotype and phenotype data relevant in an epidemiological, anthropological and forensic context. Availability and implementation: A web implementation is available at https://rhodos.ccg.uni-koeln.de/smapper/. A stand-alone version, released under the GNU General Public License version 3 as published by the Free Software Foundation, is available from https://rhodos.ccg.uni-koeln.de/smapper/software-download.php as a Singularity container (https://docs.sylabs.io/guides/latest/user-guide/index.html) and a native Linux Python installation.
- 1 January 2023
- Published by Oxford University Press (OUP) in Bioinformatics Advances
- Vol. 3 (1) , vbad176
Open AccessSMapper: visualizing spatial prevalence data of all types, including sparse and incomplete datasets
Motivation: We introduce SMapper, a novel web and software tool for visualizing spatial prevalence data of all types including those suffering from incomplete geographic coverage and insufficient sample sizes. We demonstrate the benefits of our tool in overcoming interpretational issues with existing tools caused by such data limitations. We exemplify the use of SMapper by applications to human genotype and phenotype data relevant in an epidemiological, anthropological and forensic context. Availability and implementation: A web implementation is available at https://rhodos.ccg.uni-koeln.de/smapper/. A stand-alone version, released under the GNU General Public License version 3 as published by the Free Software Foundation, is available from https://rhodos.ccg.uni-koeln.de/smapper/software-download.php as a Singularity container (https://docs.sylabs.io/guides/latest/user-guide/index.html) and a native Linux Python installation.
- Open Access
- 5 December 2022
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 11 (3)
Identification of de novo variants in nonsyndromic cleft lip with/without cleft palate patients with low polygenic risk scores
Background: Nonsyndromic cleft lip with/without cleft palate (nsCL/P) is a congenital malformation of multifactorial etiology. Research has identified >40 genome‐wide significant risk loci, which explain less than 40% of nsCL/P heritability. Studies show that some of the hidden heritability is explained by rare penetrant variants.Methods: To identify new candidate genes, we searched for highly penetrant de novo variants (DNVs) in 50 nsCL/P patient/parent‐trios with a low polygenic risk for the phenotype (discovery).We prioritized DNV‐carrying candidate genes from the discovery for resequencing in independent cohorts of 1010 nsCL/P patients of diverse ethnicities and 1574 population‐matched controls (replication). Segregation analyses and rare variant association in the replication cohort, in combination with additional data (genome‐wide association data, expression, protein–protein‐interactions), were used for final prioritization.Conclusion: In the discovery step, 60 DNVs were identified in 60 genes, including a variant in the established nsCL/P risk gene CDH1. Re‐sequencing of 32 prioritized genes led to the identification of 373 rare, likely pathogenic variants. Finally, MDN1 and PAXIP1 were prioritized as top candidates. Our findings demonstrate that DNV detection, including polygenic risk score analysis, is a powerful tool for identifying nsCL/P candidate genes, which can also be applied to other multifactorial congenital malformations.
- 5 December 2022
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 11 (3)
Open AccessIdentification of de novo variants in nonsyndromic cleft lip with/without cleft palate patients with low polygenic risk scores
Background: Nonsyndromic cleft lip with/without cleft palate (nsCL/P) is a congenital malformation of multifactorial etiology. Research has identified >40 genome‐wide significant risk loci, which explain less than 40% of nsCL/P heritability. Studies show that some of the hidden heritability is explained by rare penetrant variants.Methods: To identify new candidate genes, we searched for highly penetrant de novo variants (DNVs) in 50 nsCL/P patient/parent‐trios with a low polygenic risk for the phenotype (discovery).We prioritized DNV‐carrying candidate genes from the discovery for resequencing in independent cohorts of 1010 nsCL/P patients of diverse ethnicities and 1574 population‐matched controls (replication). Segregation analyses and rare variant association in the replication cohort, in combination with additional data (genome‐wide association data, expression, protein–protein‐interactions), were used for final prioritization.Conclusion: In the discovery step, 60 DNVs were identified in 60 genes, including a variant in the established nsCL/P risk gene CDH1. Re‐sequencing of 32 prioritized genes led to the identification of 373 rare, likely pathogenic variants. Finally, MDN1 and PAXIP1 were prioritized as top candidates. Our findings demonstrate that DNV detection, including polygenic risk score analysis, is a powerful tool for identifying nsCL/P candidate genes, which can also be applied to other multifactorial congenital malformations.
- Open Access
- 8 July 2022
- Published by Wiley in Human Mutation
- Vol. 43 (9) , 1314-1332
Benchmarking of univariate pleiotropy detection methods applied to epilepsy
Pleiotropy is a widespread phenomenon that may increase insight into the etiology of biological and disease traits. Since genome-wide association studies frequently provide information on a single trait only, only univariate pleiotropy detection methods are applicable, with yet unknown comparative performance. Here, we compared five such methods with respect to their ability to detect pleiotropy, including meta-analysis, ASSET, conditional false discovery rate (cFDR), cross-phenotype Bayes (CPBayes), and pleiotropic analysis under the composite null hypothesis (PLACO), by performing extended computer simulations that varied the underlying etiological model for pleiotropy for a pair of traits, including the number of causal variants, degree of traits' overlap, effect sizes as well as trait prevalence, and varying sample sizes. Our results indicate that ASSET provides the best trade-off between power and protection against false positives. We then applied ASSET to a previously published International League Against Epilepsy (ILAE) consortium data set on complex epilepsies, comprising genetic generalized epilepsy and focal epilepsy cases and corresponding controls. We identified a novel candidate locus at 17q21.32 and confirmed locus 2q24.3, previously identified to act pleiotropically on both epilepsy subtypes by a mega-analysis. Functional annotation, tissue-specific expression, and regulatory function analysis as well as Bayesian colocalization analysis corroborated this result, rendering 17q21.32 a worthwhile candidate for follow-up studies on pleiotropy in epilepsies.
- 8 July 2022
- Published by Wiley in Human Mutation
- Vol. 43 (9) , 1314-1332
Open AccessBenchmarking of univariate pleiotropy detection methods applied to epilepsy
Pleiotropy is a widespread phenomenon that may increase insight into the etiology of biological and disease traits. Since genome-wide association studies frequently provide information on a single trait only, only univariate pleiotropy detection methods are applicable, with yet unknown comparative performance. Here, we compared five such methods with respect to their ability to detect pleiotropy, including meta-analysis, ASSET, conditional false discovery rate (cFDR), cross-phenotype Bayes (CPBayes), and pleiotropic analysis under the composite null hypothesis (PLACO), by performing extended computer simulations that varied the underlying etiological model for pleiotropy for a pair of traits, including the number of causal variants, degree of traits' overlap, effect sizes as well as trait prevalence, and varying sample sizes. Our results indicate that ASSET provides the best trade-off between power and protection against false positives. We then applied ASSET to a previously published International League Against Epilepsy (ILAE) consortium data set on complex epilepsies, comprising genetic generalized epilepsy and focal epilepsy cases and corresponding controls. We identified a novel candidate locus at 17q21.32 and confirmed locus 2q24.3, previously identified to act pleiotropically on both epilepsy subtypes by a mega-analysis. Functional annotation, tissue-specific expression, and regulatory function analysis as well as Bayesian colocalization analysis corroborated this result, rendering 17q21.32 a worthwhile candidate for follow-up studies on pleiotropy in epilepsies.
- Retraction
- 11 December 2021
- Published by Springer Nature in Human Genetics
- Vol. 141 (1) , 175-176
Retraction Note to: Revisiting the male genetic landscape of China: a multi-center study of almost 38,000 Y-STR haplotypes
- 11 December 2021
- Published by Springer Nature in Human Genetics
- Vol. 141 (1) , 175-176
RetractionRetraction Note to: Revisiting the male genetic landscape of China: a multi-center study of almost 38,000 Y-STR haplotypes
- 21 November 2021
- Published by Wiley in Biometrical Journal
- Vol. 64 (1) , 186-187
Heterogeneity in Statistical Genetics: How to Assess, Address, and Account for Mixtures in Association Studies, by DerekGordon, Stephen J.Finch, WonkukKim2020. Cham: Springer (2020). Springer Series Statistics for Biology and Health. 352 pages. ISBN: 978‐3‐030‐61120‐0. https://doi.org/10.1007/978-3-030-61121-7
- 21 November 2021
- Published by Wiley in Biometrical Journal
- Vol. 64 (1) , 186-187
Heterogeneity in Statistical Genetics: How to Assess, Address, and Account for Mixtures in Association Studies, by DerekGordon, Stephen J.Finch, WonkukKim2020. Cham: Springer (2020). Springer Series Statistics for Biology and Health. 352 pages. ISBN: 978‐3‐030‐61120‐0. https://doi.org/10.1007/978-3-030-61121-7
- Open Access
- 19 August 2021
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 30 (2) , 249
Correction to: Towards a fine-scale picture of European genetic diversity
- 19 August 2021
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 30 (2) , 249
Open AccessCorrection to: Towards a fine-scale picture of European genetic diversity